DAWNRAYS Trademark

Trademark Overview

On Tuesday, April 27, 2010, a trademark application was filed for DAWNRAYS with the United States Patent and Trademark Office. The USPTO has given the DAWNRAYS trademark a serial number of 79085256. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 31, 2021. This trademark is owned by Suzhou Dawnrays Pharmaceutical Co., Ltd.. The DAWNRAYS trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disord...
dawnrays

General Information

Serial Number79085256
Word MarkDAWNRAYS
Filing DateTuesday, April 27, 2010
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 31, 2021
Registration Number3976651
Registration DateTuesday, June 14, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 29, 2011

Trademark Statements

Description of MarkThe mark consists of the wording "DAWNRAYS". To the left of the wording is a design element of a circle superimposed over a shaded rectangle.
Goods and ServicesChemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations in tablet form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Raw material medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemico-pharmaceutical preparations for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemical preparations for medical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Prepared traditional Chinese medicines for the treatment of respiratory system diseases, digestive system diseases, liver diseases, cardio-vascular system diseases and nervous system diseases; Medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases in humans; Medicines in capsule form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases
Pseudo MarkDAWN RAYS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "DAWNRAYS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuzhou Dawnrays Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address 215000
CN
Party NameSuzhou Dawnrays Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN
Party NameSuzhou Dawnrays Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events

Event DateEvent Description
Monday, October 24, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, September 26, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, September 26, 2022INVALIDATION PROCESSED
Wednesday, August 31, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 31, 2021CANCELLED SECTION 71
Thursday, May 14, 2020INTERNATIONAL REGISTRATION RENEWED
Friday, April 17, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 7, 2017NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
Thursday, April 6, 2017REGISTERED-SEC.71 ACCEPTED
Tuesday, March 21, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, March 9, 2017POST REGISTRATION ACTION MAILED - SEC.71
Monday, March 6, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 20, 2016TEAS SECTION 71 RECEIVED
Tuesday, September 20, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 26, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 27, 2011FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 27, 2011FINAL DISPOSITION PROCESSED
Wednesday, September 14, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 14, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, March 29, 2011PUBLISHED FOR OPPOSITION
Thursday, March 10, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 10, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 9, 2011NOTICE OF PUBLICATION
Thursday, February 24, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, February 17, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 15, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 7, 2011ASSIGNED TO LIE
Monday, January 31, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 19, 2010REFUSAL PROCESSED BY IB
Tuesday, August 24, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, August 24, 2010APPLICATION FILING RECEIPT MAILED
Monday, August 23, 2010REFUSAL PROCESSED BY MPU
Monday, August 23, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, August 22, 2010NON-FINAL ACTION WRITTEN
Friday, August 20, 2010ASSIGNED TO EXAMINER
Friday, August 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 19, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

dawnrays diseases system disorders blood endocrine urinary skin inflammatory gynecological digestive